Impushana yokusajingijolo ebomvu iyimpushana esheshayo yezinga lokudla ekhishwa esithelweni esivuthiwe sikaraspberry ngemva kokucubungula kahle. Igcina imisoco ecebile kanye nokunambitheka kwemvelo kwama-raspberries.
Ecebile ngamavithamini, ikakhulukazi uvithamini C, uvithamini E, namavithamini B ahlukahlukene, i-raspberry powder nayo iqukethe amaminerali afana ne-potassium, i-calcium, ne-magnesium. Ngaphezu kwalokho, iwumthombo omuhle we-fiber yokudla kanye nama-antioxidants, asiza ukulwa nama-radicals mahhala emzimbeni, ukubambezela ukuguga, futhi athuthukise amasosha omzimba.
I-powder inombala ogqamile kanye nokunambitheka okumnandi - okumuncu, okungasetshenziswa kabanzi embonini yokudla neziphuzo. Ivamise ukungezwa kumakhekhe, amakhukhi, iyogathi, nama-smoothies ukuze kuthuthukiswe ukunambitheka kwawo kanye nenani lokudla okunempilo. Emkhakheni wemikhiqizo yezempilo, i-raspberry powder nayo isetshenziselwa ukwenza izithako ezihlukahlukene zokudla ngenxa yempilo yayo enhle kakhulu - imiphumela ekhuthazayo.
Ama-raspberries ayaziwa ngokuthi "isithelo segolide" emhlabeni. Ngaphandle kokucebile ku-fructose, amavithamini, ama-amino acids, ukunambitheka okumnandi, okumnandi nokumuncu, kunemisebenzi emithathu yezempilo neyezokwelapha: okokuqala, umzimba womuntu ungamunca isitshalo se-SOD (superoxide dismutase) ifaka kuqala kuzo zonke izinhlobo zezithelo. Ukusetshenziswa njalo, kungasusa ama-radicals mahhala oksijini, ukuthuthukisa ukungatheleleki, ubuhle, ukulwa nokuguga; Okwesibili, okuqukethwe kwe-anti-carcinogenic yemvelo "i-tannic acid" idlula i-blueberries, ibeka kuqala phakathi kwazo zonke izinhlobo zokudla, futhi inemiphumela ekhethekile kumdlavuza wekoloni, umlomo wesibeletho, webele kanye ne-pancreatic; Okwesithathu, ecebile nge-aspirin yemvelo "salicylic acid", ingadambisa izinhlungu futhi i-antipyretic, i-anticoagulant, inganciphisa nokuvela kwe-cardiovascular and cerebrovascular embolism.
Oxhumana naye: Serena Zhao
I-WhatsApp&WeChat:+86-18009288101
I-imeyili:export3@xarainbow.com
Isikhathi sokuthumela: Mar-28-2025